Cargando…

Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors

Peptide vaccination was developed for the prevention and therapy of acute and chronic infectious diseases and cancer. However, vaccine development is challenging, because the patient immune system requires the appropriate human leukocyte antigen (HLA) recognition with the peptide. Moreover, antigens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kametani, Yoshie, Ohno, Yusuke, Ohshima, Shino, Tsuda, Banri, Yasuda, Atsushi, Seki, Toshiro, Ito, Ryoji, Tokuda, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940818/ https://www.ncbi.nlm.nih.gov/pubmed/31888191 http://dx.doi.org/10.3390/ijms20246337

Ejemplares similares

HER2-antigen-specific humoral immune response in breast cancer lymphocytes transplanted in hu-PBL hIL-4 NOG mice
por: Ohno, Yusuke, et al.
Publicado: (2021)

NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination
por: Kametani, Yoshie, et al.
Publicado: (2017)

High-progesterone environment preserves T cell competency by evading glucocorticoid effects on immune regulation
por: Kashiwagi, Hirofumi, et al.
Publicado: (2022)

Construction of the systemic anticancer immune environment in tumour-bearing humanized mouse by using liposome-encapsulated anti-programmed death ligand 1 antibody-conjugated progesterone
por: Kametani, Yoshie, et al.
Publicado: (2023)

Coccomyxa sp.KJ extract affects the fate of T cells stimulated by toxic shock syndrome toxin‐1, a superantigen secreted by Staphylococcus aureus
por: Ohshima, Shino, et al.
Publicado: (2022)

FRI374 Immunomodulatory Effects Of Progesterone And Glucocorticoids In Pregnancy Immunity
por: Yasuda, Atsushi, et al.
Publicado: (2023)

Glucocorticoid Receptor Antagonist Administration Prevents Adrenal Gland Atrophy in an ACTH-Independent Cushing's Syndrome Rat Model
por: Yasuda, Atsushi, et al.
Publicado: (2019)

A case of insulinoma effectively treated with low‐dose diazoxide
por: Yasuda, Atsushi, et al.
Publicado: (2020)

B-cell populations are expanded in breast cancer patients compared with healthy controls
por: Tsuda, Banri, et al.
Publicado: (2017)

Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope
por: Chang, Tsung-Che, et al.
Publicado: (2022)

Post-marketing Safety Evaluation of S-1 in Patients with Inoperable or Recurrent Breast Cancer: Especially in Patients Treated with S-1 + Trastuzumab
por: Saito, Yuki, et al.
Publicado: (2011)

A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC
por: Morimoto, Kenji, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review
por: Onoi, Keisuke, et al.
Publicado: (2020)

Genetic Association between Farrowing Rates and Swine Leukocyte Antigen Alleles or Haplotypes in Microminipigs
por: Ando, Asako, et al.
Publicado: (2022)

Human PZP and common marmoset A2ML1 as pregnancy related proteins
por: Kashiwagi, Hirofumi, et al.
Publicado: (2020)

Stillbirth rates and their association with swine leucocyte antigen class II haplotypes in Microminipigs
por: Imaeda, Noriaki, et al.
Publicado: (2021)

Location and expression of Juno in mice oocytes during maturation
por: Suzuki, Banri, et al.
Publicado: (2017)

Comparative immunity of antigen recognition, differentiation, and other functional molecules: similarities and differences among common marmosets, humans, and mice
por: Kametani, Yoshie, et al.
Publicado: (2018)

Preparation and characterization of monoclonal antibodies recognizing two CD4 isotypes of Microminipigs
por: Ohshima, Shino, et al.
Publicado: (2020)

Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon‐ion radiotherapy
por: Musha, Atsushi, et al.
Publicado: (2023)

Myocardial Vasculitis Associated With the Immune Checkpoint Inhibitor Pembrolizumab
por: Oishi, Hideo, et al.
Publicado: (2020)

Clinical Development of Immune Checkpoint Inhibitors
por: Ito, Ayumu, et al.
Publicado: (2015)

Production of a Locus- and Allele-Specific Monoclonal Antibody for the Characterization of SLA-1*0401 mRNA and Protein Expression Levels in MHC-Defined Microminipigs
por: Kametani, Yoshie, et al.
Publicado: (2016)

Comparison of tumor‐infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients
por: Ogiya, Rin, et al.
Publicado: (2016)

Treatment outcomes of mucosal melanoma of head and neck: Efficacy of immune checkpoint inhibitors for advanced disease
por: Ohshima, Shusuke, et al.
Publicado: (2022)

MON-348 Isolated ACTH Deficiency after Administrating Immune Checkpoint Inhibitors: Report of Three Cases and Review of Literature
por: Edo, Naoki, et al.
Publicado: (2019)

Mutations in the β-amyloid precursor protein in familial Alzheimer’s disease increase Aβ oligomer production in cellular models
por: Ohshima, Yoichi, et al.
Publicado: (2018)

Endocrinopathies Associated with Immune Checkpoint Inhibitor Cancer Treatment: A Review
por: Okura, Naoko, et al.
Publicado: (2020)

Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice
por: Inomata, Minehiko, et al.
Publicado: (2023)

Genetic Association between Swine Leukocyte antigen Class II Haplotypes and Reproduction Traits in Microminipigs
por: Ando, Asako, et al.
Publicado: (2019)

Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary Carcinoma
por: Lin, Andrew L, et al.
Publicado: (2021)

Metabolic differences and differentially expressed genes between C57BL/6J and C57BL/6N mice substrains
por: Nemoto, Shino, et al.
Publicado: (2022)

532 nm Low-Power Laser Irradiation Recovers γ-Secretase Inhibitor-Mediated Cell Growth Suppression and Promotes Cell Proliferation via Akt Signaling
por: Fukuzaki, Yumi, et al.
Publicado: (2013)

Immune checkpoint inhibitors in esophageal cancer: Clinical development and perspectives
por: Nagata, Yusuke, et al.
Publicado: (2022)

Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors–Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment
por: Yoshikawa, Yoshie, et al.
Publicado: (2020)

NOD-Rag2(null) IL-2Rγ(null) Mice: An Alternative to NOG Mice for Generation of Humanized Mice
por: Katano, Ikumi, et al.
Publicado: (2014)

Immune Checkpoint Inhibitor-Mediated Cancer Theranostics with Radiolabeled Anti-Granzyme B Peptide
por: de Aguiar Ferreira, Carolina, et al.
Publicado: (2022)

A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer
por: Cao, Shuhui, et al.
Publicado: (2022)

Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma
por: Fujimura, Taku, et al.
Publicado: (2022)

Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment
por: Murayama, Aiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0ft2l6iln77981hanpg5uap9m9